Mesenchymal Stem Cells in Chronic Lung Disease of Prematurity: Culprit or Savior?

间充质干细胞治疗早产儿慢性肺病：罪魁祸首还是救世主？

• 批准号: 269884
• 负责人: Collins Jennifer J
• 金额: $ 9.83万
• 依托单位: Ottawa Hospital Research Institute
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-10-01 至 2015-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=269884&lang=en
• 关键词: Bronchopulmonary Dysplasia; Differentiation Assays; Flow Cytometry; Lung Development; Mesenchymal Stem Cells; Oxygen Injury; Primary Cell Culture; Rat/ Baboon Model For Bpd; Stretch Injury; Transforming Growth Factor Beta

In Canada 8% of all babies are born preterm, between 24 and 37 weeks of gestational age. One of the most common complications seen in these children is bronchopulmonary dysplasia (BPD). Most preterm infants need mechanical ventilation and supplemental oxy

在加拿大，8%的婴儿是早产儿，即胎龄在24到37周之间。这些儿童最常见的并发症之一是支气管肺发育不良（BPD）。大多数早产儿需要机械通气和补充氧气